임상 한눈에 보기

• 1건의 ClinicalTrials.gov 임상 기록
• 임상시험 탭에서 enrollment 상위 목록을 불러올 수 있습니다
• 모집 중 8건 · 완료/종료 0건
• Phase: NA · PHASE1, PHASE2 · PHASE1
• Status: RECRUITING · UNKNOWN
• 주요 endpoint: Identification of a phenotypic "signature" of trogocytosis predictive of failure to achieve a complete metabolic response for patients with diffuse large B-cell lymphoma. · Identification of a phenotypic "signature" of trogocytosis predictive of the occurrence of grade II or more immunological adverse events · Identification of a phenotypic "signature" of trogocytosis predictive of the occurrence of serious hematological side effects. · Determination of the trogocytosis level of normal lymphocytes and NK cells in healthy subjects · Number of Participants With Treatment-Related Adverse Events as Assessed by CTCAE Version 5.0.
• 등록 대상자(표본 합산): 약 509명

수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다. 효능 수치는 선택한 등록 결과이며 전적응증 값이 아닙니다.